Aurélien Carnot

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Chemotherapy Induced

Clinical Evaluation

Oxide Nanoparticles

Top Venues

Cancer medicine

European journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Côme De Metz, Benjamin Hennart, Estelle Aymes, Pierre-Yves Cren, Niels Martignène, Nicolas Penel, Maël Barthoulot, Aurélien Carnot
Complete DPYD genotyping combined with dihydropyrimidine dehydrogenase phenotyping to prevent fluoropyrimidine toxicity: A retrospective study. Cancer medicine 13 (6) (2024)
Côme De Metz, Benjamin Hennart, Estelle Aymes, Pierre-Yves Cren, Niels Martignène, Nicolas Penel, Maël Barthoulot, Aurélien Carnot
Complete DPYD genotyping combined with dihydropyrimidine dehydrogenase phenotyping to prevent fluoropyrimidine toxicity: A retrospective study. Cancer medicine 13 (6) (2024)
Geoffrey Strobbe, Louise Gaboriau, Marie Abelé, Alexandre Villain, Capucine Aelbrecht-Meurisse, Aurélien Carnot, Marie-Cécile Le Deley, Clémence Léguillette, Frédéric Feutry, Ilyes Sakji, Guillaume Marliot
Impact of histamine-2 antagonist shortage on the incidence of hypersensitivity reactions to paclitaxel: a reconsideration of premedication protocols in France (PACLIREACT Study). European journal of clinical pharmacology (2023)